Use of sensitivity analysis on a physiologically based pharmacokinetic (PBPK) model for chloroform in rats to determine age-related toxicity.

被引：0
|
作者：
Eklund, CR
Simmons, JE
Evans, MV
机构：
[1] US EPA, PKB, ETD, NHEERL,ORD, Res Triangle Pk, NC 27711 USA
[2] US EPA, HEASD, NERL, ORD, Res Triangle Pk, NC 27711 USA
来源：
TOXICOLOGICAL SCIENCES | 2003年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
883
引用
收藏
页码：182 / 182
页数：1
相关论文
共 50 条
  • [31] ANALYSIS OF DRUG-DRUG INTERACTIONS BETWEEN CERIVASTATIN AND INTERACTING DRUGS, CYCLOSPORINE A AND GEMFIBROZIL, USING PHYSIOLOGICALLY BASED PHARMACOKINETIC (PBPK) MODEL
    Kim, Soo-Jin
    Yao, Yoshiaki
    Yoshikado, Takashi
    Toshimoto, Kota
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2015, 47 : 115 - 115
  • [32] Use of a physiologically based pharmacokinetic linked pharmacodynamic (pbpk-pd) model to account for adjustments to dosing of s-warfarin in different populations
    Ezuruike, U.
    Humphries, H.
    Abduljalil, K.
    Neuhoff, S.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S94 - S94
  • [33] Regression analysis of a physiologically based pharmacokinetic model (PBPK) for α1-protease-inhibitor (API) disposition after IV-infusion.
    Staschen, CM
    Bies, RR
    Holford, NHG
    Peck, CC
    Eldon, M
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P87 - P87
  • [34] A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data
    Jing-Tao Lu
    Ying Cai
    Feng Chen
    Wei-Wei Jia
    Zhe-Yi Hu
    Yuan-Sheng Zhao
    European Journal of Drug Metabolism and Pharmacokinetics, 2016, 41 : 689 - 703
  • [35] A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data
    Lu, Jing-Tao
    Cai, Ying
    Chen, Feng
    Jia, Wei-Wei
    Hu, Zhe-Yi
    Zhao, Yuan-Sheng
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2016, 41 (06) : 689 - 703
  • [36] Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences
    Quick, DJ
    Shuler, ML
    BIOTECHNOLOGY PROGRESS, 1999, 15 (03) : 540 - 555
  • [37] Use of in vitro data for construction of a physiologically based pharmacokinetic model for naphthalene in rats and mice to probe species differences
    SmithKline Beecham, 709 Swedeland Rd., King of Prussia, PA 19406, United States
    不详
    不详
    Biotechnol. Prog., 3 (540-555):
  • [38] Analysis of cyanide exposure status in fire-related deaths using a physiologically based pharmacokinetic model
    Harada, Kazuo
    Tokugawa, Yuri
    Henmi, Kazunari
    Miyashita, Yohei
    Sakahashi, Yuji
    Nishihori, Taichi
    Sakamoto, Yukari
    Yang, Chihpin
    Isobe, Yu
    Sugimoto, Kana
    Nakama, Kentaro
    Katada, Ryuichi
    Matsumoto, Hiroshi
    FORENSIC TOXICOLOGY, 2025,
  • [39] Important pharmacokinetic parameters for individualization of 177Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic model
    Hardiansyah, Deni
    Kletting, Peter
    Begum, Nusrat J.
    Eiber, Matthias
    Beer, Ambros J.
    Pawiro, Supriyanto A.
    Glatting, Gerhard
    MEDICAL PHYSICS, 2021, 48 (02) : 556 - 568
  • [40] Population-Based Analysis of Methadone Distribution and Metabolism Using an Age-Dependent Physiologically Based Pharmacokinetic Model
    Feng Yang
    Xianping Tong
    D. Gail. McCarver
    Ronald N. Hines
    Daniel A. Beard
    Journal of Pharmacokinetics and Pharmacodynamics, 2006, 33 : 485 - 518
12345